| Dr Mohana R Velagapudi, MD | |
|
525 Valley View Dr, Moline, IL 61265-6138 | |
| (309) 764-5900 | |
| (309) 764-5926 |
| Full Name | Dr Mohana R Velagapudi |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 525 Valley View Dr, Moline, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487633087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohana R Velagapudi, MD 525 Valley View Dr, Moline, IL 61265-6138 Ph: (309) 764-5900 | Dr Mohana R Velagapudi, MD 525 Valley View Dr, Moline, IL 61265-6138 Ph: (309) 764-5900 |
News Archive
A health blitz which has begun to tackle some of the health issues suffered by Aboriginal children in remote communities, is already proving to be effective.
The use of sexual aids and devices is often a sensitive and embarrassing topic for women, but a new landmark study on sexual aid usage conducted by the Berman Center and funded by an unrestricted educational grant from the Sexual Well-being store may help change women's acceptance of sexual aids
Even though previous studies have been shown the link between regular exercises and improved health the exact dose-response relation remains unclear. Guenther Samitz, researcher in physical activity and public health at the Centre for Sports Sciences and University Sports of the University of Vienna has investigated this relationship with a meta-study representing more than 1.3 million participants.
Smith & Nephew Orthopaedics Division is pleased to announce the signing of a technology development contract with the United States Department of Defense that may lead to the creation of a fracture fixation system intended to revolutionize the treatment of the limbs of soldiers who sustain battlefield injuries.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.
› Verified 9 days ago
Dr. Mark A Blaser, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 600 John Deere Road, Suite 200, Moline, IL 61265 Phone: 309-779-4200 Fax: 309-779-4305 |